1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Polshakov, V.I. Smirnov, E.G. Birdsall, B. Kelly, G. Feeney, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C21 H30 N7 O17 P3 745.421 NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C14 H19 N4 O3 1 291.326 2,4-DIAMINO-5-(3,4,5-TRIMETHOXY-BENZYL)-PYRIMIDIN-1-IUM non-polymer C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE J.Biomol.Nmr JBNME9 0800 0925-2738 24 67 70 10.1023/A:1020659713373 12449420 NMR-based solution structure of the complex of Lactobacillus casei dihydrofolate reductase with trimethoprim and NADPH 2002 NE J.Mol.Struct. JMOSB4 0119 0022-2860 602 257 267 10.1016/S0022-2860(01)00687-1 Towards understanding the origins of the different specificities of binding the reduced (NADPH) and oxydised (NADP+) forms of nicotinamide adenine dinucleotide phosphate coenzyme to dihydrofolate reductase 2002 US Biochemistry BICHAW 0033 0006-2960 38 15962 15969 10.1021/bi9915263 10625463 Characterization of rates of ring-flipping in trimethoprim in its ternary complexes with Lactobacillus casei dihydrofolate reductase and coenzyme analogues 1999 US Protein Sci. PRCIEI 0795 0961-8368 8 467 481 10.1110/ps.8.3.467 10091649 Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate 1999 UK J.Mol.Biol. JMOBAK 0070 0022-2836 277 119 134 10.1006/jmbi.1997.1560 The solution structure of the complex of Lactobacillus casei dihydrofolate reductase with methotrexate 1998 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 18331.594 DIHYDROFOLATE REDUCTASE 1.5.1.3 1 man polymer 745.421 NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE 1 syn non-polymer 291.326 2,4-DIAMINO-5-(3,4,5-TRIMETHOXY-BENZYL)-PYRIMIDIN-1-IUM 1 syn non-polymer no no TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK KA TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK KA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Lactobacillus Escherichia sample 1582 Lactobacillus casei 562 Escherichia coli NF1 PLASMID PMT702 repository Initial release Version format compliance Version format compliance Database references 1 0 2002-12-18 1 1 2008-04-28 1 2 2011-07-13 1 3 2016-12-28 1BZF contains THE SAME PROTEIN COMPLEXED WITH THE NEW LIPOPHILIC ANTIFOLATE DRUG TRIMETREXATE 1AO8 contains THE SAME PROTEIN COMPLEXED WITH METHOTREXATE 3DFR contains crystal structure of THE SAME PROTEIN COMPLEXED WITH NADPH AND METHOTREXATE RCSB Y PDBJ 2002-05-22 REL REL NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE TRR 2,4-DIAMINO-5-(3,4,5-TRIMETHOXY-BENZYL)-PYRIMIDIN-1-IUM structures with the least restraint violations 32 24 3D_15N-separated_NOESY HNHA 3D_15N-separated_ROESY 2D_N15-rejected_NOESY 2D NOESY DQF-COSY J-modulated N15, H1-HSQC J-modulated N15, H1-HSQC 100 mM KCl 6.5 ambient 308 K 10 ps at 1000K, 40 ps cooling from 1000 to 0K, 1000 steps of EM simulated annealing 1 closest to the average 3mM DHFR-15N/TMP/NADPH, 50 mM phosphate buffer 90% H2O/10% D2O 3 mM DHFR/TMP/NADPH, 50 mM phosphate buffer 100% D2O 0.5mM DHFR-15N/TMP/NADPH, 50 mM phosphate buffer, 5% DMPC/DHPC (3:1) 90% H2O/10% D2O 0.25mM DHFR-15N/TMP/NADPH, 50 mM phosphate buffer, 5% C12E5/hexanol 90% H2O/10% D2O Varian collection VNMR 6.1 Delaglio processing NMRPipe 1998-2001 Brunger structure solution CNS 0.9 Brunger refinement CNS 1.0 500 Varian UNITYPLUS 600 Varian UNITY 600 Varian INOVA NDP 168 2 NDP NDP 168 A TRR 170 3 TRR TRR 170 A THR 1 n 1 THR 1 A ALA 2 n 2 ALA 2 A PHE 3 n 3 PHE 3 A LEU 4 n 4 LEU 4 A TRP 5 n 5 TRP 5 A ALA 6 n 6 ALA 6 A GLN 7 n 7 GLN 7 A ASP 8 n 8 ASP 8 A ARG 9 n 9 ARG 9 A ASP 10 n 10 ASP 10 A GLY 11 n 11 GLY 11 A LEU 12 n 12 LEU 12 A ILE 13 n 13 ILE 13 A GLY 14 n 14 GLY 14 A LYS 15 n 15 LYS 15 A ASP 16 n 16 ASP 16 A GLY 17 n 17 GLY 17 A HIS 18 n 18 HIS 18 A LEU 19 n 19 LEU 19 A PRO 20 n 20 PRO 20 A TRP 21 n 21 TRP 21 A HIS 22 n 22 HIS 22 A LEU 23 n 23 LEU 23 A PRO 24 n 24 PRO 24 A ASP 25 n 25 ASP 25 A ASP 26 n 26 ASP 26 A LEU 27 n 27 LEU 27 A HIS 28 n 28 HIS 28 A TYR 29 n 29 TYR 29 A PHE 30 n 30 PHE 30 A ARG 31 n 31 ARG 31 A ALA 32 n 32 ALA 32 A GLN 33 n 33 GLN 33 A THR 34 n 34 THR 34 A VAL 35 n 35 VAL 35 A GLY 36 n 36 GLY 36 A LYS 37 n 37 LYS 37 A ILE 38 n 38 ILE 38 A MET 39 n 39 MET 39 A VAL 40 n 40 VAL 40 A VAL 41 n 41 VAL 41 A GLY 42 n 42 GLY 42 A ARG 43 n 43 ARG 43 A ARG 44 n 44 ARG 44 A THR 45 n 45 THR 45 A TYR 46 n 46 TYR 46 A GLU 47 n 47 GLU 47 A SER 48 n 48 SER 48 A PHE 49 n 49 PHE 49 A PRO 50 n 50 PRO 50 A LYS 51 n 51 LYS 51 A ARG 52 n 52 ARG 52 A PRO 53 n 53 PRO 53 A LEU 54 n 54 LEU 54 A PRO 55 n 55 PRO 55 A GLU 56 n 56 GLU 56 A ARG 57 n 57 ARG 57 A THR 58 n 58 THR 58 A ASN 59 n 59 ASN 59 A VAL 60 n 60 VAL 60 A VAL 61 n 61 VAL 61 A LEU 62 n 62 LEU 62 A THR 63 n 63 THR 63 A HIS 64 n 64 HIS 64 A GLN 65 n 65 GLN 65 A GLU 66 n 66 GLU 66 A ASP 67 n 67 ASP 67 A TYR 68 n 68 TYR 68 A GLN 69 n 69 GLN 69 A ALA 70 n 70 ALA 70 A GLN 71 n 71 GLN 71 A GLY 72 n 72 GLY 72 A ALA 73 n 73 ALA 73 A VAL 74 n 74 VAL 74 A VAL 75 n 75 VAL 75 A VAL 76 n 76 VAL 76 A HIS 77 n 77 HIS 77 A ASP 78 n 78 ASP 78 A VAL 79 n 79 VAL 79 A ALA 80 n 80 ALA 80 A ALA 81 n 81 ALA 81 A VAL 82 n 82 VAL 82 A PHE 83 n 83 PHE 83 A ALA 84 n 84 ALA 84 A TYR 85 n 85 TYR 85 A ALA 86 n 86 ALA 86 A LYS 87 n 87 LYS 87 A GLN 88 n 88 GLN 88 A HIS 89 n 89 HIS 89 A PRO 90 n 90 PRO 90 A ASP 91 n 91 ASP 91 A GLN 92 n 92 GLN 92 A GLU 93 n 93 GLU 93 A LEU 94 n 94 LEU 94 A VAL 95 n 95 VAL 95 A ILE 96 n 96 ILE 96 A ALA 97 n 97 ALA 97 A GLY 98 n 98 GLY 98 A GLY 99 n 99 GLY 99 A ALA 100 n 100 ALA 100 A GLN 101 n 101 GLN 101 A ILE 102 n 102 ILE 102 A PHE 103 n 103 PHE 103 A THR 104 n 104 THR 104 A ALA 105 n 105 ALA 105 A PHE 106 n 106 PHE 106 A LYS 107 n 107 LYS 107 A ASP 108 n 108 ASP 108 A ASP 109 n 109 ASP 109 A VAL 110 n 110 VAL 110 A ASP 111 n 111 ASP 111 A THR 112 n 112 THR 112 A LEU 113 n 113 LEU 113 A LEU 114 n 114 LEU 114 A VAL 115 n 115 VAL 115 A THR 116 n 116 THR 116 A ARG 117 n 117 ARG 117 A LEU 118 n 118 LEU 118 A ALA 119 n 119 ALA 119 A GLY 120 n 120 GLY 120 A SER 121 n 121 SER 121 A PHE 122 n 122 PHE 122 A GLU 123 n 123 GLU 123 A GLY 124 n 124 GLY 124 A ASP 125 n 125 ASP 125 A THR 126 n 126 THR 126 A LYS 127 n 127 LYS 127 A MET 128 n 128 MET 128 A ILE 129 n 129 ILE 129 A PRO 130 n 130 PRO 130 A LEU 131 n 131 LEU 131 A ASN 132 n 132 ASN 132 A TRP 133 n 133 TRP 133 A ASP 134 n 134 ASP 134 A ASP 135 n 135 ASP 135 A PHE 136 n 136 PHE 136 A THR 137 n 137 THR 137 A LYS 138 n 138 LYS 138 A VAL 139 n 139 VAL 139 A SER 140 n 140 SER 140 A SER 141 n 141 SER 141 A ARG 142 n 142 ARG 142 A THR 143 n 143 THR 143 A VAL 144 n 144 VAL 144 A GLU 145 n 145 GLU 145 A ASP 146 n 146 ASP 146 A THR 147 n 147 THR 147 A ASN 148 n 148 ASN 148 A PRO 149 n 149 PRO 149 A ALA 150 n 150 ALA 150 A LEU 151 n 151 LEU 151 A THR 152 n 152 THR 152 A HIS 153 n 153 HIS 153 A THR 154 n 154 THR 154 A TYR 155 n 155 TYR 155 A GLU 156 n 156 GLU 156 A VAL 157 n 157 VAL 157 A TRP 158 n 158 TRP 158 A GLN 159 n 159 GLN 159 A LYS 160 n 160 LYS 160 A LYS 161 n 161 LYS 161 A ALA 162 n 162 ALA 162 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 76 A O VAL 76 A N VAL 61 A N VAL 61 A O VAL 60 A O VAL 60 A N MET 39 A N MET 39 A N VAL 40 A N VAL 40 A O VAL 95 A O VAL 95 A O ILE 96 A O ILE 96 A N ALA 2 A N ALA 2 A N PHE 3 A N PHE 3 A O THR 112 A O THR 112 A N LEU 113 A N LEU 113 A O TRP 158 A O TRP 158 A O TYR 155 A O TYR 155 A N ARG 142 A N ARG 142 1 A A O H ALA ILE 2 96 1.56 2 A A O H ALA ILE 2 96 1.57 3 A A O H ALA ILE 2 96 1.56 5 A A O H ALA ILE 2 96 1.59 6 A A O H ALA ILE 2 96 1.56 8 A A O H ALA ILE 2 96 1.59 10 A A O H ALA ILE 2 96 1.58 12 A A O H ALA ILE 2 96 1.57 13 A A O H ALA ILE 2 96 1.59 15 A A O H ALA ILE 2 96 1.57 16 A A O H ALA ILE 2 96 1.59 17 A A O H ALA ILE 2 96 1.56 17 A A H O VAL VAL 61 74 1.60 18 A A O H ALA ILE 2 96 1.59 20 A A O H ALA ILE 2 96 1.56 1 A ILE 13 -130.91 -67.44 1 A PHE 49 -48.56 154.91 1 A ASP 78 -167.99 108.70 1 A ASP 91 -141.31 11.51 1 A ASP 111 -131.36 -35.60 2 A TRP 21 -113.84 -159.38 2 A ASP 78 -166.86 106.80 2 A GLU 93 -87.28 -159.84 3 A ILE 13 -133.43 -63.32 3 A TRP 21 -114.45 -157.51 3 A PRO 55 -48.69 156.12 3 A GLU 56 49.64 23.10 3 A ASP 78 -167.86 109.86 3 A ASP 91 -143.10 10.45 4 A LEU 19 -49.91 154.36 4 A PHE 49 -44.64 159.83 4 A ASP 78 -167.56 113.33 4 A ASP 91 -141.17 10.93 5 A ILE 13 -122.33 -65.77 5 A HIS 18 -56.67 -167.93 5 A PHE 49 -43.22 159.90 5 A ASP 78 -166.08 111.05 6 A ILE 13 -131.29 -66.88 6 A HIS 18 -56.28 -165.93 6 A ASP 78 -166.74 114.19 6 A PRO 130 -54.03 99.20 7 A ILE 13 -135.70 -62.58 7 A HIS 18 -58.18 -165.81 7 A PHE 49 -45.10 150.59 7 A ASP 78 -167.19 111.54 7 A PRO 130 -66.59 96.58 8 A ILE 13 -121.31 -66.74 8 A ASP 78 -168.75 111.39 8 A GLU 93 -90.67 -158.25 9 A HIS 18 -56.66 -165.58 9 A PHE 49 -46.12 161.88 9 A ASP 78 -166.04 109.23 10 A ILE 13 -129.71 -63.14 10 A ASP 78 -167.53 114.18 10 A PRO 130 -58.79 99.27 11 A HIS 18 -57.68 -166.57 11 A TRP 21 -113.23 -158.77 11 A PHE 49 -47.06 154.77 11 A ASP 78 -168.78 107.18 11 A ASP 91 -140.33 10.82 12 A ILE 13 -130.95 -67.30 12 A LEU 19 -48.93 164.32 12 A TRP 21 -112.98 -158.57 12 A ASP 78 -166.43 108.13 13 A HIS 18 -55.25 -171.62 13 A GLU 56 49.95 22.96 13 A HIS 77 -141.45 33.73 13 A ASP 78 -167.88 108.94 13 A ASP 91 -140.59 13.00 13 A ASP 111 -134.41 -31.01 14 A ILE 13 -127.70 -67.41 14 A HIS 18 -54.78 -175.09 14 A PHE 49 -49.11 155.75 14 A PRO 55 -68.82 93.44 14 A ASP 78 -165.78 105.35 15 A HIS 18 -56.81 -166.13 15 A TRP 21 -112.01 -157.87 15 A PHE 49 -48.36 156.98 15 A ASP 78 -167.31 108.66 15 A ASP 91 -140.11 10.50 16 A HIS 18 -54.29 -174.72 16 A PHE 49 -48.07 164.32 16 A ASP 78 -168.11 108.75 17 A ILE 13 -127.47 -68.04 17 A ASP 78 -170.14 112.95 17 A ASP 91 -140.76 11.22 18 A ILE 13 -129.31 -66.89 18 A HIS 18 -54.31 -173.42 18 A ASP 78 -167.32 109.65 18 A ASP 91 -140.74 13.13 18 A ASP 111 -132.09 -35.26 19 A ILE 13 -133.23 -56.91 19 A HIS 18 -58.26 -163.55 19 A PHE 49 -49.22 152.70 19 A ASP 78 -165.10 106.63 19 A PRO 130 -66.89 99.88 20 A ILE 13 -121.87 -68.38 20 A PHE 49 -47.93 153.80 20 A ASP 78 -168.13 107.79 21 A TRP 21 -111.93 -157.43 21 A ASP 78 -166.70 107.91 21 A GLU 93 -87.58 -157.70 22 A ILE 13 -134.57 -61.61 22 A PHE 49 -44.88 155.56 22 A ASP 78 -163.53 107.98 22 A ASP 111 -131.41 -33.03 23 A PHE 49 -41.13 159.27 23 A ASP 78 -169.33 113.18 24 A PHE 49 -43.64 154.22 24 A ASP 78 -167.83 110.19 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) SOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH, 24 STRUCTURES 1 N N 2 N N 3 N N A LEU 23 A LEU 23 HELX_P A THR 34 A THR 34 1 1 12 A ARG 43 A ARG 43 HELX_P A PHE 49 A PHE 49 1 2 7 A ASP 78 A ASP 78 HELX_P A HIS 89 A HIS 89 1 3 12 A GLY 99 A GLY 99 HELX_P A PHE 106 A PHE 106 1 4 8 A ASN 132 A ASN 132 HELX_P A ASP 134 A ASP 134 5 5 3 OXIDOREDUCTASE DHFR, INHIBITOR-ENZYME COMPLEX, OXIDOREDUCTASE A ARG 52 A ARG 52 1 A PRO 53 A PRO 53 -0.88 A GLY 98 A GLY 98 1 A GLY 99 A GLY 99 0.96 A ARG 52 A ARG 52 2 A PRO 53 A PRO 53 -0.97 A GLY 98 A GLY 98 2 A GLY 99 A GLY 99 0.89 A ARG 52 A ARG 52 3 A PRO 53 A PRO 53 -0.44 A GLY 98 A GLY 98 3 A GLY 99 A GLY 99 1.04 A ARG 52 A ARG 52 4 A PRO 53 A PRO 53 -0.12 A GLY 98 A GLY 98 4 A GLY 99 A GLY 99 1.00 A ARG 52 A ARG 52 5 A PRO 53 A PRO 53 -0.88 A GLY 98 A GLY 98 5 A GLY 99 A GLY 99 1.00 A ARG 52 A ARG 52 6 A PRO 53 A PRO 53 0.01 A GLY 98 A GLY 98 6 A GLY 99 A GLY 99 1.00 A ARG 52 A ARG 52 7 A PRO 53 A PRO 53 0.50 A GLY 98 A GLY 98 7 A GLY 99 A GLY 99 1.38 A ARG 52 A ARG 52 8 A PRO 53 A PRO 53 -0.22 A GLY 98 A GLY 98 8 A GLY 99 A GLY 99 0.91 A ARG 52 A ARG 52 9 A PRO 53 A PRO 53 -0.28 A GLY 98 A GLY 98 9 A GLY 99 A GLY 99 0.91 A ARG 52 A ARG 52 10 A PRO 53 A PRO 53 -0.67 A GLY 98 A GLY 98 10 A GLY 99 A GLY 99 1.34 A ARG 52 A ARG 52 11 A PRO 53 A PRO 53 -1.04 A GLY 98 A GLY 98 11 A GLY 99 A GLY 99 0.81 A ARG 52 A ARG 52 12 A PRO 53 A PRO 53 -0.32 A GLY 98 A GLY 98 12 A GLY 99 A GLY 99 0.92 A ARG 52 A ARG 52 13 A PRO 53 A PRO 53 -0.22 A GLY 98 A GLY 98 13 A GLY 99 A GLY 99 1.06 A ARG 52 A ARG 52 14 A PRO 53 A PRO 53 -0.71 A GLY 98 A GLY 98 14 A GLY 99 A GLY 99 1.10 A ARG 52 A ARG 52 15 A PRO 53 A PRO 53 -0.67 A GLY 98 A GLY 98 15 A GLY 99 A GLY 99 1.03 A ARG 52 A ARG 52 16 A PRO 53 A PRO 53 -0.84 A GLY 98 A GLY 98 16 A GLY 99 A GLY 99 0.90 A ARG 52 A ARG 52 17 A PRO 53 A PRO 53 -0.94 A GLY 98 A GLY 98 17 A GLY 99 A GLY 99 1.23 A ARG 52 A ARG 52 18 A PRO 53 A PRO 53 -0.48 A GLY 98 A GLY 98 18 A GLY 99 A GLY 99 1.09 A ARG 52 A ARG 52 19 A PRO 53 A PRO 53 -0.98 A GLY 98 A GLY 98 19 A GLY 99 A GLY 99 1.23 A ARG 52 A ARG 52 20 A PRO 53 A PRO 53 0.07 A GLY 98 A GLY 98 20 A GLY 99 A GLY 99 1.13 A ARG 52 A ARG 52 21 A PRO 53 A PRO 53 -0.57 A GLY 98 A GLY 98 21 A GLY 99 A GLY 99 1.16 A ARG 52 A ARG 52 22 A PRO 53 A PRO 53 -0.02 A GLY 98 A GLY 98 22 A GLY 99 A GLY 99 1.29 A ARG 52 A ARG 52 23 A PRO 53 A PRO 53 0.06 A GLY 98 A GLY 98 23 A GLY 99 A GLY 99 1.03 A ARG 52 A ARG 52 24 A PRO 53 A PRO 53 0.15 A GLY 98 A GLY 98 24 A GLY 99 A GLY 99 1.05 DYR_LACCA UNP 1 1 P00381 TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK KA 1 162 1LUD 1 162 P00381 A 1 1 162 8 parallel parallel parallel parallel parallel anti-parallel anti-parallel A VAL 74 A VAL 74 A VAL 76 A VAL 76 A THR 58 A THR 58 A LEU 62 A LEU 62 A ILE 38 A ILE 38 A GLY 42 A GLY 42 A LEU 94 A LEU 94 A GLY 98 A GLY 98 A ALA 2 A ALA 2 A GLN 7 A GLN 7 A THR 112 A THR 112 A LEU 118 A LEU 118 A HIS 153 A HIS 153 A LYS 160 A LYS 160 A PHE 136 A PHE 136 A VAL 144 A VAL 144 BINDING SITE FOR RESIDUE NDP A 168 Software 20 BINDING SITE FOR RESIDUE TRR A 170 Software 13 A TRP 5 A TRP 5 20 1_555 A ALA 6 A ALA 6 20 1_555 A ILE 13 A ILE 13 20 1_555 A GLY 14 A GLY 14 20 1_555 A LYS 15 A LYS 15 20 1_555 A GLY 17 A GLY 17 20 1_555 A GLY 42 A GLY 42 20 1_555 A ARG 43 A ARG 43 20 1_555 A ARG 44 A ARG 44 20 1_555 A THR 45 A THR 45 20 1_555 A LEU 62 A LEU 62 20 1_555 A THR 63 A THR 63 20 1_555 A HIS 64 A HIS 64 20 1_555 A GLN 65 A GLN 65 20 1_555 A ALA 97 A ALA 97 20 1_555 A GLY 99 A GLY 99 20 1_555 A ALA 100 A ALA 100 20 1_555 A GLN 101 A GLN 101 20 1_555 A ILE 102 A ILE 102 20 1_555 A TRR 170 C TRR 20 1_555 A LEU 4 A LEU 4 13 1_555 A TRP 5 A TRP 5 13 1_555 A ALA 6 A ALA 6 13 1_555 A GLY 17 A GLY 17 13 1_555 A LEU 19 A LEU 19 13 1_555 A ASP 26 A ASP 26 13 1_555 A LEU 27 A LEU 27 13 1_555 A PHE 30 A PHE 30 13 1_555 A PHE 49 A PHE 49 13 1_555 A PRO 50 A PRO 50 13 1_555 A ALA 97 A ALA 97 13 1_555 A THR 116 A THR 116 13 1_555 A NDP 168 B NDP 13 1_555 1 P 1